Novartis India Ltd. Schedules Board Meeting to Review Q1 Unaudited Financial Results
Novartis India Limited has scheduled a meeting of its Board of Directors to review and approve the company's Unaudited Financial Results for the quarter ending June 30, 2026. The board meeting is set to take place on Thursday, July 23, 2026.The purpose of the gathering is to consider and approve the Unaudited Financial Results of Novartis India Limited for the specified period. This meeting follows the scheduled intimation regarding the company's operations.
NOVARTIND Stock Price Movement
Shares of Novartis India Limited are edging higher to ₹1464 as of 3:15 PM today, climbing 0.45% in live trading. The stock saw movement on 4,275 shares during the ongoing market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.